RBRichard Joseph Burman

Richard Joseph Burman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard Joseph Burman has a total of 246 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Meningioma regression following depot medroxyprogesterone acetate withdrawal: a case series

    by Byron De John, Richard J. Burman, Vishesh Sood, Allan Taylor, David Le Feuvre, Darlene Lubbe

    Background Progesterone signalling is a key determinant of meningioma behaviour, particularly in skull base tumours. Cyproterone acetate-associated meningiomas stabilise or regress after withdrawal Whether similar reversibility follows cessation of depot medroxyprogesterone acetate (DMPA), a widely used long-acting injectable contraceptive, is poorly characterised.Methods Retrospective case series of three women with intracranial meningiomas who discontinued DMPA following neurosurgical assessment, assessed with post-contrast CT (Cases 1 and 2) or magnetic resonance imaging (Case 3).Results All had prolonged DMPA exposure (approximately 14–27 years) and predominantly skull base disease with WHO grade I meningothelial histology. Each demonstrated measurable regression of enhancing soft-tissue tumour after cessation, despite marked heterogeneity in disease burden and chronicity, including one patient with multifocal meningiomatosis and more than a decade of documented progression. Hyperostotic bone showed no regression, and two patients required optic nerve and orbital decompression for progressive visual loss despite soft-tissue regression.Conclusion DMPA-associated meningiomas can regress following drug withdrawal, but the response is confined to the soft-tissue component. Persistent hyperostosis may continue to cause compression, and withdrawal should not be assumed to remove the need for surgery. These findings support routine assessment of progestin exposure in patients with meningioma.


  • Open Access

    Pediatric epilepsy surgery: Global survey of invasive explorations

    by Georgia Ramantani, Martha Feucht, Dorottya Cserpan, Javier Aparicio, Alexis Arzimanoglou, Fabrice Bartolomei, William Bingaman, Kees P. J. Braun, Richard J. Burman, Dezhi Cao, et al.

    Objective: Invasive presurgical evaluation plays a key role in pediatric epilepsy surgery, particularly in magnetic resonance imaging (MRI)‐negative cases, by guiding resective, disconnective, or ablative procedures. This International League Against Epilepsy (ILAE) Pediatric Epilepsy Surgery Taskforce study provides an updated global overview of current invasive evaluation practices. Methods: Group‐level data were collected from 61 epilepsy surgery programs (49 pediatric‐only) in 29 countries across six continents. Included were children and adolescents who underwent presurgical evaluation and epilepsy surgery in 2023. The study was designed to enable comparison with the similar ILAE survey conducted in 2004. Results: A total of 2427 patients were included. Invasive evaluations were performed in 21.1% of cases, most frequently in North America (33.7%, higher than Europe: 18.0%, p = .003). Among invasive cases, 32.3% had no detectable MRI abnormalities. The main indication for invasive evaluation was seizure onset localization (88.1%), followed by motor or sensory mapping (17.2%) and language mapping (14.2%). Stereoelectroencephalography (SEEG) was the predominant technique (19.8% overall, 93.6% of invasive cases), more common in North America (30.0%, p = .021) and less common in South America (7.4%, p < .001). Subdural electrodes were used in only 3.2% of invasive cases, and combined depth and subdural approaches in 3.2%. SEEG‐guided radiofrequency thermocoagulation (RF‐TC) was performed in 40.9% of SEEG cases, most commonly in Asia (63.8%). In 16.2% of invasive evaluations, patients did not proceed to resection, disconnection, or ablation, with the highest rate in Europe (28.5%). Significance: This global survey provides the first broad overview of invasive evaluation practices in pediatric epilepsy surgery across participating centers worldwide. It highlights the widespread adoption of SEEG, declining use of subdural electrodes, and increasing application of SEEG‐guided RF‐TC. The high proportion of MRI‐negative cases and the considerable proportion of patients not proceeding to resection, disconnection, or ablation underscore the complexity of contemporary surgical candidates and the need for further refinement of selection strategies.


  • Open Access

    Opposing intrinsic and synaptic plasticity mechanisms stabilize altered cortical networks during sleep deprivation

    by Richard J. Burman, Paul Brodersen, Hannah Alfonsa, Vladyslav V. Vyazovskiy, Colin J. Akerman

    Sleep deprivation alters brain activity and impairs performance, yet many aspects of behaviour are preserved in this state. In the cortex for example, sleep deprivation increases neuronal firing rates and low-frequency oscillatory activity, but cortical circuits continue to process information. Recent work has implicated synaptic inhibition in these changes, with sleep deprivation causing cortical GABA A receptor (GABA A R) signalling to become depolarizing due to changes in chloride gradients that determine the GABA A R reversal potential (E GABAAR ). The impact in the intact brain remains unclear, however, as both the degree and effects of E GABAAR changes depend on network activity and intrinsic properties of neurons. To address this, we perform in vivo gramicidin recordings from cortical pyramidal neurons in sleep-deprived mice. We reveal that synaptic E GABAAR is depolarised to values sufficient to support bona fide excitatory GABA A R signalling, through combined network-dependent and cell-autonomous effects. In the face of this depolarizing drive, cortical neurons engage spike threshold adaptation mechanisms that limit their excitability. These opposing effects stabilise activity in simulations of sleep-deprived cortical networks and reproduce the increased firing rates and low-frequency oscillatory activity. This interplay between intrinsic and synaptic mechanisms may help maintain network stability during sleep deprivation, while reducing flexibility for subsequent adaptation.

  • Open Access

    Pediatric epilepsy surgery: Global survey of referral and presurgical evaluation practices

    by Georgia Ramantani, J. Helen Cross, Dorottya Cserpan, Emtnan Ahemad, Javier Aparicio, Alexis Arzimanoglou, Carmen Barba, William Bingaman, Kees Braun, Richard J. Burman, et al.

    Objective: Pediatric epilepsy surgery is well established, but contemporary global data on referral and presurgical evaluation practices are lacking. This International League Against Epilepsy (ILAE) Pediatric Epilepsy Surgery Task Force study provides an updated overview of current trends and regional differences. Methods: Group‐level data were collected from 61 epilepsy surgery programs (49 pediatric‐only) across 29 countries and six continents, identified through ILAE networks, and included all children and adolescents treated in 2023 who underwent presurgical evaluation/epilepsy surgery. Results: Group‐level data were available for 2427 patients. Mean age at surgery was 9.1 ± 4.9 years; mean epilepsy duration was 5.3. At surgery, 3.2% were 5 years. Reoperations are common, with resection more frequent than neuromodulation. Genetic testing in nearly half of patients reflects its growing relevance, and the high rate of DEEs underscores the complexity of surgical candidates.


  • Open Access

    The association between depot medroxyprogesterone acetate and meningiomas: Emerging data and their relevance to the South African context

    by R J Burman, R De Waal, K Cohen, M Blockman, M Patel, D Hockman, D M Fountain, S Jeyaretna, S Singh, H Mustak, et al.

    In the past 2 years, evidence suggesting an association between depot medroxyprogesterone acetate (dMPA) use and meningioma has emerged. As dMPA remains one of the most widely used contraceptive methods worldwide, this finding has led to increasing media attention, and regulatory and legal proceedings. The South African Health Products Regulatory Authority (SAHPRA) has issued a statement acknowledging the association between dMPA exposure and the development for meningiomas. However, the paucity of local data on dMPA use and the incidence of and risk factors for meningioma in both the public and private health sector make it difficult to fully assess the implications in SA. This report discusses the relevance of the association between dMPA and meningiomas in the SA context. We provide a summary of the current data on the risk of meningioma with dMPA exposure, and suggest how this should impact on recommendations for the prescribing and use of dMPA from a public health perspective. We further identify gaps in local data, and propose where efforts should be directed to collect relevant data to inform a rational national contraceptive strategy.


  • Open Access

    Distinct clinical clusters of paediatric patients with status epilepticus: Retrospective cohort study

    by Richard J Burman, Anne Steinberg, Jamie Norris, Giorgio Selmin, Tommaso Fedele, Richard E Rosch, Georgia Ramantani

    Aim: To characterize the clinical features, management, and outcomes of paediatric patients with status epilepticus, and to explore whether distinct clinical subgroups can be identified from clinical descriptions. Method: This was an exploratory retrospective single‐centre cohort study of paediatric status epilepticus admissions to Switzerland's largest tertiary‐level paediatric hospital. We analysed 642 status epilepticus admissions from 467 patients (230 females; median age at first 4 years 11 months [interquartile range 1 year 5 months–7 years 5 months]). We applied descriptive statistics and machine‐learning approaches. A k ‐means clustering algorithm was used to identify distinct clinical subgroups, while least absolute shrinkage and selection operator regression tested whether clinical metrics could predict mortality. Results: Age‐related differences in status epilepticus aetiology were observed: infants and younger children more often presented with acute symptomatic causes, whereas older children and adolescents were more likely to have pre‐existing epilepsy. Out‐of‐hospital treatment was associated with faster treatment initiation and better treatment response. Shorter status epilepticus onset to treatment latency correlated with higher response rates and reduced need for intensive care. Cluster analysis identified three clinical subgroups: (1) younger patients with acute status epilepticus associated with an infection, including febrile status epilepticus (‘febrile seizure’ cluster); (2) younger patients with acute status epilepticus and a more severe in‐hospital course (‘para‐infectious’ cluster); and (3) older patients with an established epilepsy diagnosis (‘known epilepsy’ cluster). Across the cohort, progressive epilepsy aetiology and a previous diagnosis of epilepsy were associated with increased mortality risk. Interpretation: Paediatric status epilepticus comprises clinically distinct subgroups that are identifiable from routine clinical data. Such data‐driven clinical clustering may help refine risk stratification and inform clinical decision making in paediatric status epilepticus.


  • Open Access

    Personalized care of paediatric drug‐resistant epilepsy in Africa: A single‐centre pilot study utilizing mobile health and genetic testing

    by Ian S Olivier, Karen Fieggen, Sandra Komarzynski, Elin H Davies, Irene Muchada, Caitlin McIntosh, Alina Esterhuizen, Richard J Burman, Jo M Wilmshurst, the University of Cape Town (UCT) Human Genetics Precision Medicine Epilepsy Group

    Aim: To evaluate personalized care or precision medicine initiatives, including mobile health (mHealth) technology and genetic screening, in a South African paediatric epilepsy clinic. Method: This exploratory prospective observational pilot study included 39 children aged 4 years or older with drug‐resistant epilepsy (ongoing seizures despite at least two antiseizure medications at adequate doses). Participants were recruited from the epilepsy service at the Red Cross War Memorial Children's Hospital in Cape Town, the largest paediatric hospital in sub‐Saharan Africa. mHealth technology – a wearable device and mobile application – allowed recording of seizures, medication, sleep, mobility, quality of life, and health visits. Genetic testing included a customized gene panel and pharmacogenomic arrays. Results: Seizure frequency, but not duration, was significantly greater in clinical records before and during the study period (8.0 and 5.5 median seizures per month respectively) compared with mHealth records of 2.0 median seizures per month ( n = 28, p < 0.001, r = 0.64, 95% confidence interval [CI] 2.62–14.25, Wilcoxon signed‐rank test, and n = 21, p < 0.001, r = 0.76, 95% CI 2.25–15.75, Wilcoxon signed‐rank test respectively). Wearable devices detected decreased activity and sleep in patients compared with age‐matched typically developing peers (both p < 0.001, Mann–Whitney U test). Structural abnormalities were the most common aetiology. Pathogenic variants occurred in two different probands in SCN1A , one likely pathogenic variant in GRIN2A , and two variants of unknown significance in GABRG2 and GRIN2B . Pharmacogenomic analyses identified variants of interest in CYP2D6 , EPHX1 , and SCN1A . Interpretation: Precision medicine for drug‐resistant epilepsy using mHealth and genetics may show use in a resource‐limited setting. This study, the first demonstration of precision medicine in an African paediatric setting, informs the development of diagnostic testing and provides novel insights into the lives and genetics of affected children.


  • Open Access

    Local cortical inhibitory subnetworks are shaped by pyramidal neuron progenitor type

    by Gemma Gothard, Kashif Mahfooz, Sarah E. Newey, Sasha Tinelli, Matthew J. Buchan, Richard J. Burman, Colin J. Akerman

    The degree to which cortical neurons share inhibitory synaptic input determines their co-activity within a network. However, the principles by which inhibition is shared between neurons are not known. Here we combine in utero labeling with in vivo two-photon targeted patch-clamp recordings in mature cortex to reveal that a layer 2/3 (L2/3) pyramidal neuron’s local inhibitory input reflects the embryonic progenitor type from which the neuron is born. In contrast to neighboring neurons, pyramidal neurons derived from intermediate progenitors receive synaptic inhibition that is weakly coupled to local network activity. The underlying mechanisms do not depend upon the amount of inhibitory input received from different interneuron subclasses. Rather, progenitor type defines how much inhibitory input a neuron shares with its neighbors, which is reflected in how individual interneurons target pyramidal neurons according to progenitor type. These findings reveal new significance for progenitor diversity and identify ontogenetic origins of fine-scale inhibitory cortical subnetworks.

  • Open Access

    Network models incorporating chloride dynamics predict optimal strategies for terminating status epilepticus

    by Christopher B. Currin, Richard J. Burman, Tommaso Fedele, Georgia Ramantani, Richard E. Rosch, Henning Sprekeler, Joseph V. Raimondo

    Seizures that continue for beyond five minutes are classified as status epilepticus (SE) and constitute a medical emergency. Benzodiazepines, the current first-line treatment, attempt to terminate SE by increasing the conductance of chloride-permeable type-A GABA receptors (GABA A Rs). Despite their widespread use, benzodiazepines are ineffective in over a third of cases. Previous research in animal models has demonstrated that changes in intraneuronal chloride homeostasis and GABA A R physiology may underlie the development of benzodiazepine resistance in SE. However, there remains a need to understand the effect of these changes at a network level to improve translation into the clinical domain. Therefore, informed by data from human EEG recordings of SE and experimental brain slice recordings, we used a large spiking neural network model that incorporates chloride dynamics to investigate and address the phenomenon of benzodiazepine resistance in SE. We found that the GABA A R reversal potential (E GABA ) sets SE-like bursting and determines the response to GABA A R conductance modulation, with benzodiazepines being anti-seizure at low E GABA and ineffective or pro-seizure at high E GABA . The SE-like activity and E GABA depended on a non-linear relationship between the strength of Cl - extrusion and GABA A R conductance, but not on the initial E GABA of neurons. Independently controlling Cl - extrusion in the pyramidal and interneuronal cell populations revealed the critical role of pyramidal cell Cl - extrusion in determining the severity of SE activity and the response to simulated benzodiazepine application. Finally, we demonstrate the model’s utility for considering improved therapeutic approaches for terminating SE in the clinic.

  • Open Access

    All-optical reporting of inhibitory receptor driving force in the nervous system

    by Joshua S. Selfe, Teresa J. S. Steyn, Eran F. Shorer, Richard J. Burman, Kira M. Düsterwald, Ahmed S. Abdelfattah, Eric R. Schreiter, Sarah E. Newey, Colin J. Akerman, Joseph Valentino Raimondo

    Ionic driving forces provide the net electromotive force for ion movement across receptors, channels, and transporters, and are a fundamental property of all cells. In the brain for example, fast synaptic inhibition is mediated by chloride permeable GABAA receptors, and single-cell intracellular recordings have been the only method for estimating driving forces across these receptors (DFGABAA). Here we present a new tool for quantifying inhibitory receptor driving force named ORCHID: all-Optical Reporting of CHloride Ion Driving force. We demonstrate ORCHID’s ability to provide accurate, high-throughput measurements of resting and dynamic DFGABAA from genetically targeted cell types over multiple timescales. ORCHID confirms theoretical predictions about the biophysical mechanisms that establish DFGABAA, reveals novel differences in DFGABAA between neurons and astrocytes, and affords the first in vivo measurements of intact DFGABAA. This work extends our understanding of inhibitory synaptic transmission and establishes a precedent for all-optical methods to assess ionic driving forces.